Treatment for acute repetitive seizures is evolving, driven by advances in drug delivery, digital health, and seizure detection. These innovations are reshaping the acute repetitive seizures market and improving outcomes for patients and caregivers.
Drug delivery innovation is a major focus. Intranasal and buccal benzodiazepine formulations offer rapid, non-invasive administration, enabling...
